Changing cannabis laws is only part of improving treatment, a pharmacist has said ahead of an event next week examining the evidence, prescribing and patient care behind medical cannabis.
Nitin Makadia, director of clinical service development at The Digital Health Assurance Company, is due to speak about what Germany can learn from medical cannabis care elsewhere in Europe at the Cannabis Health Symposium in Frankfurt on 4 November.
The company helps healthcare providers set up and run clinical services, including supporting medical cannabis clinics with patient safety and regulatory requirements.
Makadia brings 35 years of experience in pharmacy, healthcare operations and digital health.
“Regulatory reform opens doors, but robust clinical governance, safety standards, and practical operational models are what turn policies into safe, sustainable patient care,” he said.
He will join the panel “Medical Cannabis in Europe: What Other Markets Can Teach German Practice”, alongside José Tempero, director of international medical affairs at Tilray Medical, and Dirk Heitepriem, president of German cannabis business association BvCW.
The Cannabis Health Symposium takes place at Mainhaus, Frankfurt, on 4 November. Tickets and the full programme are available here.
